ZEISS Cataract & Refractive Clinical Cases
As a world innovation leader in optics and one of the most respected brands in medical technology ZEISS shares on a regular basis exciting clinical cases from the field of ophthalmology. Leading cataract and refractive surgeons around the globe contribute to the know-how transfer within the community providing us with interesting cases they mastered in their daily practice. See how expert knowledge paired with innovative technology can significantly improve patients lives.
PRESBYOND Laser Blended Vision from ZEISS – the procedure for compensating presbyopia
By: Lílìana Bànyai
ZEISS PRESBYOND is a good choice for patients without cataract to compensate presbyopia with laser vision correction. Read about the importance of a careful preoperative evaluation and patient education to achieve good clinical results.
New EDoF toric IOL from ZEISS as additional option for individualized patient care
By: Florian T.A. Kretz, MD
The new ZEISS AT LARA toric used by Dr. Kretz to treat his own refractive manager has proven excellent visual outcomes, resulting in high spectacle independence and great patient satisfaction.
ReLEx SMILE from ZEISS – A good choice for a presbyopic ametropic patient.
By: Jakob Siedlecki
A case highlighting the role for SMILE® to provide monovision and spectacle independence as an effective and safe treatment for a presbyopic ametropic patient.
Outcomes of post-SMILE Cataract Surgery with Multifocal IOL Implantation: The Benefit of Total Keratometry for Power Calculation
By: Sri Ganesh and Sheetal Brar
Sri Ganesh and Sheetal Brar describe their first experience performing cataract surgery in a post-SMILE® patient. They used an IOLMaster 700 with Total Keratometry and achieved an excellent refractive outcome.
New EDoF IOL from ZEISS: optimal for elderly cataract patients with active lifestyle
By: Pascal Rozot
ZEISS AT LARA provides good far and intermediate vision that may be extended for near using micro-monovision: Ideal for patients wishing spectacle independence and non-eligible for multifocal IOLs.